CBIO
Dimensional Fund Advisors’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-23,156
| Closed | -$69.5K | – | 3391 |
|
|
2024
Q1 | $69.5K | Buy |
+23,156
| New | +$69.5K | ﹤0.01% | 3303 |
|
|
2023
Q4 | – | Sell |
-44,532
| Closed | -$66.8K | – | 3432 |
|
|
2023
Q3 | $66.8K | Hold |
44,532
| – | – | ﹤0.01% | 3359 |
|
|
2023
Q2 | $77.5K | Sell |
44,532
-22,253
| -33% | -$38.7K | ﹤0.01% | 3361 |
|
|
2023
Q1 | $84.1K | Sell |
66,785
-7,493
| -10% | -$9.44K | ﹤0.01% | 3326 |
|
|
2022
Q4 | $225 | Buy |
+74,278
| New | +$225 | ﹤0.01% | 3204 |
|
|
2022
Q2 | – | Sell |
-271,129
| Closed | -$309K | – | 3492 |
|
|
2022
Q1 | $309K | Sell |
271,129
-293,259
| -52% | -$334K | ﹤0.01% | 3243 |
|
|
2021
Q4 | $813K | Sell |
564,388
-340,240
| -38% | -$490K | ﹤0.01% | 3073 |
|
|
2021
Q3 | $1.98M | Sell |
904,628
-274,310
| -23% | -$601K | ﹤0.01% | 2857 |
|
|
2021
Q2 | $2.74M | Sell |
1,178,938
-35,649
| -3% | -$82.7K | ﹤0.01% | 2792 |
|
|
2021
Q1 | $3.66M | Buy |
1,214,587
+6,467
| +0.5% | +$19.5K | ﹤0.01% | 2676 |
|
|
2020
Q4 | $4.54M | Buy |
1,208,120
+11,195
| +0.9% | +$42.1K | ﹤0.01% | 2555 |
|
|
2020
Q3 | $3.68M | Buy |
1,196,925
+18,795
| +2% | +$57.7K | ﹤0.01% | 2552 |
|
|
2020
Q2 | $4.43M | Buy |
1,178,130
+2,799
| +0.2% | +$10.5K | ﹤0.01% | 2517 |
|
|
2020
Q1 | $2.68M | Buy |
1,175,331
+126,378
| +12% | +$288K | ﹤0.01% | 2614 |
|
|
2019
Q4 | $5.55M | Buy |
1,048,953
+9,208
| +0.9% | +$48.7K | ﹤0.01% | 2578 |
|
|
2019
Q3 | $4.48M | Buy |
1,039,745
+52,456
| +5% | +$226K | ﹤0.01% | 2638 |
|
|
2019
Q2 | $11.8M | Buy |
987,289
+120,327
| +14% | +$1.43M | ﹤0.01% | 2332 |
|
|
2019
Q1 | $10.8M | Buy |
866,962
+249,542
| +40% | +$3.11M | ﹤0.01% | 2375 |
|
|
2018
Q4 | $5.85M | Buy |
617,420
+228,664
| +59% | +$2.17M | ﹤0.01% | 2554 |
|
|
2018
Q3 | $5.6M | Buy |
+388,756
| New | +$5.6M | ﹤0.01% | 2644 |
|